| Primary |
| Hypertension |
39.0% |
| Pulmonary Hypertension |
12.2% |
| Atrial Fibrillation |
7.3% |
| Oedema |
7.3% |
| Arteriosclerosis Coronary Artery |
4.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.9% |
| Tachyarrhythmia |
4.9% |
| Cardiac Disorder |
2.4% |
| Cardiac Failure Congestive |
2.4% |
| Constipation |
2.4% |
| Depression |
2.4% |
| Diarrhoea |
2.4% |
| Hyperthyroidism |
2.4% |
| Insulin Resistance |
2.4% |
| Oedema Peripheral |
2.4% |
|
| Blood Pressure Increased |
8.3% |
| Cardiac Arrest |
8.3% |
| Drug Interaction |
8.3% |
| Hypokalaemia |
8.3% |
| Hyponatraemia |
8.3% |
| Ischaemic Stroke |
8.3% |
| Muscular Weakness |
8.3% |
| Neck Pain |
8.3% |
| Presyncope |
8.3% |
| Renal Failure Acute |
8.3% |
| Syncope |
8.3% |
| Weight Decreased |
8.3% |
|
| Secondary |
| Hypertension |
35.6% |
| Product Used For Unknown Indication |
23.5% |
| Type 2 Diabetes Mellitus |
6.9% |
| Prostate Cancer Metastatic |
4.0% |
| Oedema Peripheral |
3.6% |
| Vitamin Supplementation |
2.8% |
| Cardiac Disorder |
2.4% |
| Depression |
2.4% |
| Atrial Fibrillation |
2.0% |
| Pulmonary Tuberculosis |
2.0% |
| Status Epilepticus |
2.0% |
| Essential Hypertension |
1.6% |
| Organ Transplant |
1.6% |
| Prostatitis |
1.6% |
| Pulmonary Hypertension |
1.6% |
| Constipation |
1.2% |
| Drug Use For Unknown Indication |
1.2% |
| Hyperlipidaemia |
1.2% |
| Hyperthyroidism |
1.2% |
| Insulin Resistance |
1.2% |
|
| Renal Failure Acute |
14.8% |
| Hyponatraemia |
11.1% |
| Vomiting |
11.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
5.6% |
| Hyperkalaemia |
5.6% |
| Hypotension |
5.6% |
| Renal Injury |
5.6% |
| Anaemia |
3.7% |
| Condition Aggravated |
3.7% |
| Drug-induced Liver Injury |
3.7% |
| Hypertension |
3.7% |
| Lactic Acidosis |
3.7% |
| Prostatitis |
3.7% |
| Renal Failure Chronic |
3.7% |
| Status Epilepticus |
3.7% |
| Treatment Noncompliance |
3.7% |
| Atrioventricular Block Second Degree |
1.9% |
| Blood Pressure Increased |
1.9% |
| Cardiac Arrest |
1.9% |
| Cardiac Failure Congestive |
1.9% |
|
| Concomitant |
| Hypertension |
20.9% |
| Drug Use For Unknown Indication |
12.8% |
| Product Used For Unknown Indication |
8.8% |
| Rheumatoid Arthritis |
6.6% |
| Pain |
6.4% |
| Gastrooesophageal Reflux Disease |
4.9% |
| Vitamin Supplementation |
4.7% |
| Osteoporosis |
4.1% |
| Depression |
3.4% |
| Blood Cholesterol Increased |
3.0% |
| Blood Pressure |
3.0% |
| Prophylaxis |
3.0% |
| Blood Cholesterol |
2.9% |
| Nausea |
2.5% |
| Cardiac Disorder |
2.2% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Hyperlipidaemia |
2.2% |
| Prostate Cancer |
2.2% |
| Breast Cancer |
2.0% |
| Cardiovascular Disorder |
2.0% |
|
| Vertigo |
12.4% |
| Vomiting |
10.1% |
| Varices Oesophageal |
9.0% |
| Syncope |
6.7% |
| Cardiac Arrest |
4.5% |
| Drug Interaction |
4.5% |
| Hypoxia |
4.5% |
| Nausea |
4.5% |
| Pneumonia |
4.5% |
| Therapeutic Response Decreased |
4.5% |
| Weight Decreased |
4.5% |
| Acute Coronary Syndrome |
3.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.4% |
| Oedema Peripheral |
3.4% |
| Pulmonary Fibrosis |
3.4% |
| Red Blood Cell Sedimentation Rate Increased |
3.4% |
| Renal Failure Acute |
3.4% |
| Sinusitis |
3.4% |
| Somnolence |
3.4% |
| Suicide Attempt |
3.4% |
|
| Interacting |
| Cardiac Failure |
40.0% |
| Hypertension |
40.0% |
| Atrial Fibrillation |
20.0% |
|
| Drug Interaction |
33.3% |
| Hypocalcaemia |
22.2% |
| Renal Failure Acute |
22.2% |
| Dizziness |
11.1% |
| Toxicity To Various Agents |
11.1% |
|
